Researchers at the University of Illinois at Chicago and Queensland University of Technology of Australia, have developed a device that can isolate individual cancer cells from patient blood samples.
The microfluidic device works by separating the various cell types found in blood by their size. The device may one day enable rapid, cheap liquid biopsies to help detect cancer and develop targeted treatment plans. The findings are reported in the journal Microsystems & Nanoengineering.
“This new microfluidics chip lets us separate cancer cells from whole blood or minimally-diluted blood,” said Ian Papautsky, the Richard and Loan Hill Professor of Bioengineering in the UIC College of Engineering and corresponding author on the paper. “While devices for detecting cancer cells circulating in the blood are becoming available, most are relatively expensive and are out of reach of many research labs or hospitals. Our device is cheap, and doesn’t require much specimen preparation or dilution, making it fast and easy to use.”
The ability to successfully isolate cancer cells is a crucial step in enabling liquid biopsy where cancer could be detected through a simple blood draw. This would eliminate the discomfort and cost of tissue biopsies which use needles or surgical procedures as part of cancer diagnosis. Liquid biopsy could also be useful in tracking the efficacy of chemotherapy over the course of time, and for detecting cancer in organs difficult to access through traditional biopsy techniques, including the brain and lungs.
However, isolating circulating tumor cells from the blood is no easy task, since they are present in extremely small quantities. For many cancers, circulating cells are present at levels close to one per 1 billion blood cells. “A 7.5-milliliter tube of blood, which is a typical volume for a blood draw, might have ten cancer cells and 35-40 billion blood cells,” said Papautsky. “So we are really looking for a needle in a haystack.”
Microfluidic technologies present an alternative to traditional methods of cell detection in fluids. These devices either use markers to capture targeted cells as they float by, or they take advantage of the physical properties of targeted cells — mainly size — to separate them from other cells present in fluids.
Papautsky and his colleagues developed a device that uses size to separate tumor cells from blood. “Using size differences to separate cell types within a fluid is much easier than affinity separation which uses ‘sticky’ tags that capture the right cell type as it goes by,” said Papautsky. “Affinity separation also requires a lot of advanced purification work which size separation techniques don’t need.”
The Latest on: Cancer blood test
via Google News
The Latest on: Cancer blood test
- Prostate cancer: 'Misinterpretation' of urinary symptoms causing more deaths - new studyon August 3, 2022 at 8:00 pm
PROSTATE cancer is the most common type of cancer found in men, with more than 52,000 diagnoses in the UK every year. As with all cancers, the sooner you spot the signs the better chance of survival ...
- PCPs Stepping In for Care of Cancer Patientson August 3, 2022 at 8:40 am
As the number of cancer survivors rises, primary care specialists are playing an increasingly important role in managing these patients.
- A new microfluidic system could keep tabs on cancer treatmenton August 3, 2022 at 8:20 am
Found in a patient's blood, circulating tumor cells, or CTCs, have powerful potential to indicate how well a cancer treatment is working and guide treatment decisions. Even so, CTC technologies have ...
- Simple blood test could help doctors identify early signs of brain tumouron August 3, 2022 at 12:58 am
A simple blood test to detect the early signs of a brain tumour could soon be possible thanks to emerging research that uses computer modelling to spot telltale signs of cancer. Researchers at the ...
- Blood test can now detect breast cancer at Apollo Cancer Centreon August 2, 2022 at 5:11 pm
BHUBANESWAR: Apollo Cancer Centre in association with Datar Cancer Genetics has introduced a revolutionary blood test that can detect breast cancer at early stages in asymptomatic individuals with ...
- New research could lead to simple blood test for brain tumourson August 2, 2022 at 4:03 pm
The development of a simple blood test for glioblastomas (GBMs) could mean earlier diagnosis and more effective and personalised treatment options. Bristol-led research, published in the journal The ...
- New research could lead to a simple blood test for brain tumorson August 2, 2022 at 4:00 pm
University of Bristol research could lead to better detection of the most common type of malignant brain cancer.
- Early-Detection Blood Tests for Pancreatic Canceron August 1, 2022 at 1:45 am
Learn about early-detection blood tests for pancreatic cancer — those that are currently available as well as tests that could become available in the future.
- New blood test at Mercy could give peace of mind to families with history of aggressive cancerson July 29, 2022 at 8:30 am
The test is meant to complement — not replace — regular cancer screenings, like ones for breast, colon, cervical, lung and prostate cancers.
- New blood test could 'transform' cancer treatment: B.C. researchon July 28, 2022 at 9:09 pm
A new study out of the University of British Columbia has found that more personalized cancer treatments can be developed by drawing just a few drops of blood from a patient.
via Bing News